Miguel
Alcoceba Sánchez
Investigador desde 2011
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (10)
2023
2022
-
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Blood Advances, Vol. 6, Núm. 21, pp. 5763-5773
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671
-
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
Histopathology, Vol. 81, Núm. 6, pp. 826-840
2020
-
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
British Journal of Haematology, Vol. 190, Núm. 6, pp. 854-863
-
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Blood Cancer Journal, Vol. 10, Núm. 10
-
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Blood Cancer Journal, Vol. 10, Núm. 2
2019
-
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma
Leukemia and Lymphoma
-
Vitamin D modifies the incidence of graft-versus-host disease after allogeneic stem cell transplantation depending on the Vitamin D Receptor (VDR) polymorphisms
Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4616-4623
2018
-
Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series
Annals of Hematology, Vol. 97, Núm. 12, pp. 2417-2424